Keyword: Bristol-Myers Squibb (BMS)
News
14.04.2016
- Bristol-Myers Squibb’s cancer drug Opdivo can now be used to treat more patients with lung cancer or kidney cancer after European regulators expanded its indications. The EU...
Markets & Companies
04.04.2016
- Analysts love looking into the future, particularly when it comes to big pharma’s prospect for growth and earnings. The industry experts of Morningstar see slowing patent losses...
News
24.03.2016
- US drugmaker Bristol-Myers Squibb (BMS) has signed an agreement to acquire Padlock Therapeutics, a privately owned biotechnology firm based at Cambridge, Massachusetts, which...
Chemistry & Life Sciences
03.02.2016
- A key upcoming industry event is DCAT Week, the flagship event of the Drug, Chemical & Associated Technologies Association (DCAT). DCAT Week brings together pharmaceutical and...
News
13.01.2016
- Five major internationally active drugmakers, including American biotech firms Amgen and Celgene, along with pharmaceutical giant Pfizer and non-US players such as Glaxo SmithKline...
Markets & Companies
07.10.2015
- The pharmaceutical industry is entering a period of sustained growth. Prescription drug sales are set to advance at almost 5% a year until 2020, while worldwide prescription drug...
Markets & Companies
07.10.2015
- After a challenging second quarter and first half 2015 – once again marked by foreign exchange turbulence and the impact of acquisitions and divestments – the international...
Strategy & Management
07.10.2015
- Allotrope Foundation, an international consortium of pharmaceutical and biopharmaceutical companies with a common vision to develop innovative new approaches for handling data in R...
